| Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data TP Vogel, KA Top, C Karatzios, DC Hilmers, LI Tapia, P Moceri, ... Vaccine 39 (22), 3037-3049, 2021 | 237 | 2021 |
| Serious neurological adverse events after ivermectin—do they occur beyond the indication of onchocerciasis? RE Chandler The American journal of tropical medicine and hygiene 98 (2), 382, 2018 | 135 | 2018 |
| Vasculitis as an adverse event following immunization–systematic literature review C Bonetto, F Trotta, P Felicetti, GS Alarcón, C Santuccio, NS Bachtiar, ... Vaccine 34 (51), 6641-6651, 2016 | 120 | 2016 |
| Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase® RE Chandler, K Juhlin, J Fransson, O Caster, IR Edwards, GN Norén Drug safety 40, 81-90, 2017 | 111 | 2017 |
| Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response S Baral, R Chandler, RG Prieto, S Gupta, S Mishra, M Kulldorff Annals of epidemiology 54, 21-26, 2021 | 67 | 2021 |
| Optimizing safety surveillance for COVID-19 vaccines RE Chandler Nature reviews immunology 20 (8), 451-452, 2020 | 62 | 2020 |
| Spontaneous reports of vasculitis as an adverse event following immunization: a descriptive analysis across three international databases P Felicetti, F Trotta, C Bonetto, C Santuccio, YB Pernus, D Burgner, ... Vaccine 34 (51), 6634-6640, 2016 | 51 | 2016 |
| Safety concerns reported by patients identified in a collaborative signal detection workshop using VigiBase: results and reflections from Lareb and Uppsala Monitoring Centre S Watson, RE Chandler, H Taavola, L Härmark, B Grundmark, A Zekarias, ... Drug safety 41, 203-212, 2018 | 46 | 2018 |
| Risk factor considerations in statistical signal detection: using subgroup disproportionality to uncover risk groups for adverse drug reactions in VigiBase L Sandberg, H Taavola, Y Aoki, R Chandler, GN Norén Drug safety 43 (10), 999-1009, 2020 | 40 | 2020 |
| Kawasaki disease and immunisation: A systematic review LK Phuong, C Bonetto, J Buttery, YB Pernus, R Chandler, P Felicetti, ... Vaccine 35 (14), 1770-1779, 2017 | 40 | 2017 |
| Data-driven identification of adverse event reporting patterns for Japan in VigiBase, the WHO global database of individual case safety reports R Wakao, H Taavola, L Sandberg, E Iwasa, S Soejima, R Chandler, ... Drug Safety 42, 1487-1498, 2019 | 35 | 2019 |
| Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors RE Chandler, K Hedberg, PR Cieslak Infection Control & Hospital Epidemiology 28 (2), 116-122, 2007 | 34 | 2007 |
| The role of pharmacovigilance and ISoP during the global COVID-19 pandemic RE Chandler, D McCarthy, JC Delumeau, M Harrison-Woolrych Drug Safety 43 (6), 511-512, 2020 | 32 | 2020 |
| Transmission of Group A Streptococcus Limited to Healthcare Workers with Exposure in the Operating Room RE Chandler, LE Lee, JM Townes, RA Taplitz Infection Control & Hospital Epidemiology 27 (11), 1159-1163, 2006 | 30 | 2006 |
| Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events RE Chandler BMJ 365, 2019 | 23 | 2019 |
| Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety–executive summary U Heininger, K Holm, I Caplanusi, SR Bailey, SA Abdoellah, F Arellano, ... Vaccine 35 (32), 3917-3921, 2017 | 23 | 2017 |
| Safety concerns with HPV vaccines continue to linger: are current vaccine pharmacovigilance practices sufficient? RE Chandler Drug Safety 40 (12), 1167-1170, 2017 | 22 | 2017 |
| Kawasaki disease and immunisation: standardised case definition & guidelines for data collection, analysis LK Phuong, C Bonetto, J Buttery, YB Pernus, R Chandler, KL Goldenthal, ... Vaccine 34 (51), 6582-6596, 2016 | 21 | 2016 |
| IgA vasculitis (Henoch-Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data A Woerner, C Rudin, C Bonetto, C Santuccio, S Ozen, RP Wise, ... Vaccine 35 (11), 1559-1566, 2017 | 18 | 2017 |
| Progress in immunization safety monitoring—worldwide, 2010–2019 O Salman MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 17 | 2021 |
